The Scandinavian Sarcoma Group—background, organization and the SSG Register—the first 25 years

Acta Orthopaedica Scandinavica

Volumn 75, Issue sup311, 2004, Pages 1-7

  Alvegard T A ^a   Bauer, H ^b   Blomqvist, C ^c   Rydholm, A ^d   Smeland, S ^e  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^d Dept of Orthopedic Surgery ^*  (Sweden)

^e OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BONE TUMOR; HEALTH CARE ORGANIZATION; HUMAN; MULTICENTER STUDY; ORGANIZATION AND MANAGEMENT; REGISTER; RESEARCH; SARCOMA; SCANDINAVIA; SOFT TISSUE TUMOR; ADJUVANT CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER THERAPY; CLINICAL EXAMINATION; CLINICAL RESEARCH; EWING SARCOMA; MEDICAL SERVICE; MEDICAL SPECIALIST; MULTIVARIATE ANALYSIS; MUSCULOSKELETAL SYSTEM; OSTEOSARCOMA; PATHOLOGIST; PATIENT REFERRAL; PREOPERATIVE TREATMENT; PROGNOSIS; RADIOLOGIST; REVIEW; SOCIAL STRUCTURE; SURGEON; SURVIVAL RATE;

BONE NEOPLASMS; HUMANS; MULTICENTER STUDIES; REGISTRIES; RESEARCH; SARCOMA; SCANDINAVIA; SOCIETIES; SOFT TISSUE NEOPLASMS;

ANTINEOPLASTIC AGENT; CISPLATIN; DOXORUBICIN; IFOSFAMIDE; METHOTREXATE;

EID: 2342564414     PISSN: 00016470     EISSN: 17453682     Source Type: Journal    
DOI: 10.1080/00016470410001708250     Document Type: Article

References (39)

1. Alho A, Alvegird T A, Berlin O, Ranstam J, Rydholm A, Rooser B, Stener B for the Scandinavian Sarcoma Group. Surgical margin in soft tissue sarcoma. The Scandinavian Sarcoma Group experience. Acta Orthop Scand 1989; 60 (6): 687 – 92.
2. Alvegfird T A, Solheim O, Elomaa I. Ewing's sarcoma — a preliminary report from the Scandinavian Sarcoma Group. Acta Oncol 1989 (Suppl 2); 28: 59 – 64.
3. Alvegfird T A. Management and prognosis of patients with high-grade soft tissue sarcomas. An evaluation of a Scan-dinavian joint care program. University of Lund (thesis), (1989) Lund.
4. Alvegfird T A, Sigurdsson H, Mouridsen H, Solheim O, Unsgaard B, Ringborg U, Dahl O, Nordentoft A M, Blomqvist C, Rydholm A, Stener B, Ranstam J. Adjuvant chemotherapy with Doxorubicin in high-grade soft tissue sarcoma: A randomized trial of the Scandinavian Sarcoma Group. J Clin Oncol 1989; 7: 1504 – 13.
5. Alvegfird T A, Berg N O. Histopathology peer review of high-grade soft tissue sarcoma. The Scandinavian Sar-coma Group experience. J Clin Oncol 1989; 7: 1845 – 51.
6. Alvegfird TA, Berg NO, Ranstam J, Rydholm A, Miser B. Prognosis in high-grade soft tissue sarcomas. The Scan-dinavian Sarcoma Group experience in a randomized adjuvant chemotherapy trial. Acta Orthop Scand 1989; 60 (5): 517 – 21.
7. Alvegfird TA, Berg N O, Baldetorp B, Ferno M, Killander D, Ranstam J, Rydholm A, Akerman M. Cellular DNA content and prognosis of high grade soft tissue sarcoma. The Scandinavian Sarcoma Group experience. J Chin Oncol 1990; 8: 538 – 47.
8. Alvegfird T A. List of publications from the Scandinavian Sarcoma Centers. Scandinavian Sarcoma secretariat. 1994; 125: 1989 – 93.
9. Bacci G, Ferrari S, Longhi A, Picci P, Mercuri M, Alvegard TA, Saeter G, Conati D, Manfrini M, Lan S, Briccoli A, Forth C. High Dose Ifosfamide in Combination with High Dose Methotrexate, Adriamycin and Cisplatin in the Neo-adjuvant Treatment of Extremity Osteosarcoma: Prelimi-nary Results of an Italian Sarcoma Group/Scandinavian Sarcoma Pilot Study. J Chemoth 2002; 14 (2): 198 – 206.
10. Bauer HCF, Alvegird TA, Berlin O, Erlanson M, Kalen, A, Lindholm P, Gustafson P, Smeland S, Trovik CS. The Scandinavian sarcoma register 1986–2002. Acta Orthop Scand 2004; (Suppl 311): 8 – 10.
11. Bauer HCF, Moller T, Alvegird TA, Rydholm A, Gustafson P, Solheim O, Erlanson M, Karlsson M, Monge O, Trovik, Blomqvist C, Wiklund T, Berlin O, Turesson I. Moni-toring referral and treatment in soft tissue sarcoma: Study based on 1851 patients from the Scandinavian Sarcoma Group Register. Acta Orthop Scand 2001; 72: 150 – 9.
12. Elomaa I, Blomqvist C, Saeter G, Nilbert M, Monge O, Wiebe T, Alvegfird T A. Chemotherapy in Ewing's sar-coma—the Scandinavian Sarcoma Group experience. Acta Orthop Scand 1999; Suppl 285: 69 – 73.
13. Elomaa I, Blomqvist C, Saeter G, Akerman M, Stenwig E, Wiebe T, Björk O, Alvegird TA. Five-year results in Ewing's sarcoma. The the Scandinavian Sarcoma Group experience with the SSG XI protocol. Eur J Cancer 2000; 36: 875 – 80.
14. Gustafson P. Soft tissue sarcoma. Epidemiology and prog-nosis in 508 patients. Acta Orthop Scand 1994; 65 (Suppl 259): 131.
15. Gustafson P, Akerman M, Alvegird T A, Coindre J M, Fletcher C D M, Rydholm A, Willén H. Prognostic infor-mation in soft tissue sarcoma using tumour size, vascular invasion, and microscopic tumour necrosis — the SIN-system. Eur J Cancer 2003; 39: 1568 – 76.
16. Hansen BH, Wedin R, Keller J, Laitinen M, Berg P, Skjeldal S, Trovik C, Nilsson J, Walloe A, Kalen A. The Scandi-navian sarcoma group skeletal metastasis register. Sur-vival after surgery for bone metastases in the pelvis and extremities. Acta Ortop Scand 2004 (in press).
17. Nilbert M, Saeter G, Elomaa I, Monge O, Wiebe T, Alvegird T. Ewing's sarcoma treatment in Scandinavia 1984–1990. Acta Oncol 1998; 37(4); 375 – 78.
18. Rydholm A. Management of patients with soft—tissue tumors. Strategy developed at a regional oncology center. Acta Orthop Scand 1983; (Suppl 203): 54.
19. Rydholm A. Centralization of soft tissue sarcoma. The southern Sweden experience. Acta Orthop Scand 1997; 68 (Suppl 273): 4 – 8.
20. Rydholm A, Alvegird T. Scandinavian Sarcoma Group, Goteborg, Sweden, May 5-7, 1993. Acta Orthop Scand 1994a; 65 (Suppl 265): 55 – 72.
21. Rydholm A, Alvegird T A. Scandinavian Sarcoma Group, Helsinki, April 10-22, 1994. Acta Orthop Scand 1994b; 65 (Suppl 262): 63 – 80.
22. Rydholm A, Alvegird T A. Scandinavian Sarcoma Group, Stockholm, April 26-28, 1995. Acta Orthop Scand 1995; 66 (Suppl 265): 89 – 100.
23. Rydholm A, Alvegird T A. Scandinavian Sarcoma Group, Reykjavik, May 7-9, 1996. Acta Orthop Scand 1996; 67 (Suppl 272): 41 – 59.
24. Rydholm A, Alvegird T A. Scandinavian Sarcoma Group, Trondheim, April 16-18, 1997. Acta Orthop Scand 1997; 68 (Suppl 274): 65 – 77.
25. Rydholm A, Alvegird T A. Scandinavian Sarcoma Group, Snekkersten, April 22-24, 1998. Acta Orthop Scand 1998; 69 (Suppl 282): 25 – 43.
26. Smeland S, Muller C, Alvegird TA, Wiklund T, Wiebe T, Björk O, Stenwig AE, Willén H, Holmstrom T, Follerfis G, Brosjö O, Kivioja A, Jonsson K, Monge O, Saeter G. Scandinavian Sarcoma Group Osteosarcoma Study SSG VIII: prognostic factors for outcome and the role of replacement salvage chemotherapy for poor histological responders. Eur J Cancer 2003; 39: 488 – 94.
27. Smeland S, Wiebe T, Brosjö O, Bohling T, Alvegird TA. Chemotherapy in Ewing's sarcoma — The Scandinavian Sarcoma Group experience. Acta Orthop Scand 2004;
28. Solheim O, Alvegird T A, Elomaa I. Adjuvant chemo-therapy for osteosarcoma a preliminary report from the Scandinavian Sarcoma Group. Acta Oncol 1989 (Suppl 2); 28: 53 – 7.
29. Solheim O, Alvegird T A. The Scandinavian Sarcoma Group. 10 Years' experience. Acta Oncol 1989 (Suppl 2); 28: 175.
30. Solheim O, Saeter G, Elomaa I, Alvegird T A. The treat-ment of osteosarcoma: Present trends. The Scandinavian Sarcoma Group experience. Annals of Oncology 1992 (Suppl 2); 3: 711.
31. Saeter G, Alvegfird TA, Elomaa I, Stenwig E, Holmstrom T, Solheim O. Treatment of osteosarcoma of the extremities with the T10 protocol, with emphasis on the effects of preoperative chemotherapy with single agent high—dose methotrexate. A Scandinavian Sarcoma Group study. J Clin Oncol 1991; 9: 1766 – 75.
32. Saeter G, Strander H, Monge O R, Alvegfird T A. Dose escalating etoposide (E), ifosfamide (I) and granulocyte colony stimulating factor (GCSF) (VI Gregimen) in advanced adult soft tissue sarcoma. A Scandinavian Sar-coma Group study. Ann Oncol 1994 (5 suppl); 8: 171.
33. Saeter G, Talle K, Solheim O. Treatment of advanced, high—grade soft—tissue sarcoma with ifosfamide and continuos infusion etoposide. Cancer Chemotherapy and Pharmacology 1995; 36: 172 – 5.
34. Saeter G, Alvegird T A, Monge O, Strander H, Turesson I, Klepp R, Soderberg M, Wist E, Raabe N, Erlanson M, Solheim O, Hannisdal E. Ifosfamide and continuous infusion etoposide in advanced adult soft tissue sarcoma. A Scandinavian Sarcoma Group Phase II Study. Eur J Cancer 1997; 33 (10): 1551 – 8
35. Saeter G for the Scandinavian Sarcoma Group. Treatment of osteosarcoma with high—dose methotrexate containing neoadjuvant chemotherapy. Scandinavian Sarcoma Group data. Med Ped Oncol 1996a; 27 (4): 263.
36. Saeter G for the Scandinavian Sarcoma Group. Treatment strategies and outcome in metastatic (relapsed) osteo-genic sarcoma. The Scandinavian Sarcoma Group (SSG) experience. Med Ped Oncol 1996b; 27 (4): 264.
37. Tierney J F, Mosseri V, Stewart LA, Souhami R L, Parmar M K. Adjuvant chemotherapy for soft—tissue sarcoma: review and meta—analysis of the published results of ran-domized clinical trials. Br J Cancer 1995; 72: 469 – 75.
38. Tierney J F. Adjuvant chemotherapy for localized resectable soft—tissue sarcoma of adults: meta—analysis of individual data. Sarcoma meta—analysis collaboration. Lancet 1997; Vol 350 No 9092, 1647 – 54.
39. Wiklund T A, Alvegird T A, Mouridsen H T, Rydholm A, Blomqvist C P. Marginal surgery and postoperative radiotherapy in soft tissue sarcomas. Eur J Cancer 1993; 29A: 30 – 69.